(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘triple aim
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
September 30, 2024
FDA approves highly anticipated first-in-class drug for schizophrenia: BMS’ Cobenfy
Read More
September 23, 2024
FTC sues 3 largest PBMs and their GPOs, alleging they inflated insulin prices
Read More
September 16, 2024
Senate committee to vote on holding Steward Health Care CEO in contempt for refusing to testify at hearing
Read More
September 09, 2024
Pfizer launches digital DTC platform, following Eli Lilly’s lead
Read More
August 26, 2024
Judge blocks noncompete ban nationwide; not clear if FTC will appeal
Read More
August 19, 2024
Harris offers glimpse into her plans for health care if she is elected
Read More
August 12, 2024
Walgreens sells Cencora shares, mulls selling VillageMD, while CVS plans to trim costs by $2 billion
Read More
August 05, 2024
Hospitals and health systems in multiple states caught up in midsummer spate of M&A activity
Read More
July 29, 2024
Congressional committee grills top PBM bosses in hearing, House releases investigation report
Read More
July 22, 2024
Steward Health subject of DOJ fraud investigation as Senate committee launches probe into bankruptcy
Read More
July 15, 2024
WSJ: FTC plans to sue 3 largest PBMs over pricing tactics
Read More
July 01, 2024
Walgreens retreats, Amazon Clinic restructures, and Walmart Health is history
Read More
June 24, 2024
Risant Health sets its sights on a second acquisition: Cone Health
Read More
June 17, 2024
In unanimous votes, FDA advisory committee favors approval of Lilly’s donanemab
Read More
Posts navigation
1
2
…
9
Next
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
First name
*
Last name
*
Email
*
Company
*
Job Title
*
Thank you for signing up! Check your inbox or spam folder to confirm your subscription.
share
Consulting
Insights
Podcast
DVI
About
Contact Us
